Notarangelo Luigi, Casanova Jean-Laurent, Fischer Alain, Puck Jennifer, Rosen Fred, Seger Reinhard, Geha Raif
Department of Pediatrics, University of Brescia Spedali Civili, Brescia, Italy.
J Allergy Clin Immunol. 2004 Sep;114(3):677-87. doi: 10.1016/j.jaci.2004.06.044.
Although relatively rare, primary immune deficiency diseases (PIDs) provide an excellent window into the functioning of the immune system. In the late 1960s, observations on these diseases, with their associated infections and genetics, bisected the immune system into humoral immunity and cell-mediated immunity. These diseases also represent a challenge in their diagnosis and treatment. Beginning in 1970, a unified nomenclature for the then-known primary immunodeficiency diseases was created by a committee convened by the World Health Organization. Since then, and later under the aegis of the International Union of Immunological Societies, an international committee of experts has met every 2 to 3 years to update the classification of PIDs. During the past 15 years, the molecular basis of more than 100 PIDs has been elucidated. This update results from the latest meeting of this committee in Sintra, Portugal, June 2003, which followed 2(1/2) days of scientific discussions.
尽管原发性免疫缺陷病(PIDs)相对罕见,但却是洞察免疫系统功能的绝佳窗口。20世纪60年代末,对这些疾病及其相关感染和遗传学的观察将免疫系统一分为二,即体液免疫和细胞介导免疫。这些疾病在诊断和治疗方面也构成挑战。从1970年开始,世界卫生组织召集的一个委员会为当时已知的原发性免疫缺陷病制定了统一的命名法。从那时起,后来在国际免疫学会联盟的支持下,一个国际专家委员会每2至3年召开一次会议,更新原发性免疫缺陷病的分类。在过去15年里,100多种原发性免疫缺陷病的分子基础已被阐明。本次更新源于该委员会2003年6月在葡萄牙辛特拉举行的最新会议,此前进行了两天半的科学讨论。